The coordination of cell proliferation and differentiation is central to the development and maintenance of tissues, while its dysregulation underlies the transition to diseased states. By combining lineage tracing with transcriptional profiling and marker-based assays, statistical methods are delivering insights into the dynamics of stem cells and their developmental precursors. These studies have provided evidence for molecular heterogeneity and fate priming, and have revealed a role for stochasticity in stem cell fate, refocusing the search for regulatory mechanisms. At the same time, they present a quantitative platform to study the initiation and progression of disease. Here, we review how quantitative lineage tracing strategies are shaping our understanding of the cellular mechanisms of tissue development, maintenance and disease.
in a heterogeneous and dynamic environment where gene expression levels adjust in response to promoter activity and environmental cues. Therefore, to define the mechanisms that underpin cell fate, transcriptional information must be integrated with dynamic measures that address functional behaviour.
In the earliest form of lineage tracing, tritiated thymidine incorporation was used as a surrogate clonal marker [1] . Using such methods, C.P. LeBlond, a pioneer of modern stem cell biology, made significant progress in defining stem cell identity in a variety of epithelial tissues [2] [3] [4] . Later, lineage tracing strategies based on the incorporation of marker genes by electroporation [5] and lentiviral transfection [6] , provided the means to impart hereditary marks on cells. However, it was not until the advent of transgenic animal technology that it became possible to trace the fate of individual cells and their progeny using targeted promoters. These days, intra-vital imaging platforms are providing access to continuous-time lineage data [7-9], while single-cell DNA sequencing methods offer the potential to resolve phylogenies in human tissues [10] [11] [12] .
Advances in lineage tracing and molecular profiling techniques provide access to information at the cellular and molecular scale. Yet the integration of these measures into new mechanistic insights presents a formidable challenge. In recent years, the development of quantitative statistical methods, based on concepts from statistical physics and mathematics, are gaining traction in biology. These approaches, which place emphasis on "emergent behaviour" and scaling phenomena, provide constraints on the molecular mechanisms that regulate proliferative activity, fate choice and the collective dynamics of stem and progenitor cell populations. Beginning with a review of current lineage tracing strategies, here we provide an overview of how quantitative analysis of clonal data can be used to define mechanisms of cell fate choice in tissue development, maintenance and diseased states.
Lineage tracing strategies
Through advances in transgenics, multiple tracing strategies are available [13, 14] . In the Cre-lox system, the expression of Cre recombinase is placed under the control of a cell-specific promoter [15] . Following the administration of a drug-inducing agent, the transient expression of Cre leads to the excision of a stop cassette, resulting in the activation of a fluorescent reporter gene. By using targeted promoters, this method allows the controlled labelling of distinct subpopulations at clonal or mosaic density (Figure 1a,b) . By coupling the fluorescent reporter to the activation of an oncogene, such methods are increasingly deployed to trace steps in tumour progression, from initiation to invasion [16] .
Despite their power, the reliability of genetic labelling assays may be compromised by (the lack of) promoter specificity, toxicity of the Cre enzyme or drug-inducing agent [17] , and the faithful identification of clones. In the process of tissue or tumour development, large-scale cell rearrangements may lead to the fragmentation of labelled clones into disconnected cell clusters. Similarly, at non-clonal labelling density, initially separate clones may merge and form cohesive groups of labelled cells of non-clonal origin. Although the impact of clone merger and fragmentation events may be mitigated by multicolour (Brainbow or Confetti) reporter constructs [18, 19] , such effects cannot be eradicated. However, recent progress in the development of statistical analytical methods provide rigorous quantitative measures that allow lineage relationships to be inferred even from non-clonal density labelling [20] .
Although clonal tracing studies provide indirect insight into the fate of marked cells, as a static measure based on the analysis of fixed samples, detailed information on individual fate histories is invariably lost. In the Mosaic Analysis with Double Marker (MADM) system, through Cre-induced mitotic recombination, fluorescent reporter genes of distinct colour can be activated in sister cells (Figure 1c,d ), allowing definitive lineage information to be recovered [21] . Moreover, by correlating the expression of an oncogene with only one of the fluorescent proteins, the MADM system allows the mutual interaction of mutant and wild-type clones to be studied in situ.
The dispersion of cells in the blood system renders traditional "few-colour" labelling strategies impractical as a lineage tracing system. Here, efforts have been made to increase the spectrum of lineage labels so that clonal information can be recovered.
To this end, approaches have been developed based on the incorporation of genetic "barcodes" using lentiviral vectors [22] as well as the activation of transposons [23] .
To study proliferation kinetics and resolve slow-cycling cell populations, emphasis has been placed on the H2B-GFP system in which the expression of GFP fused to histone 2B is made dependent on the presence of Doxycycline (DOX) [24]: In this approach, H2B-GFP is homogeneously expressed in dividing cells. Upon DOX administration, H2B-GFP production is repressed such that, post-induction, the cellular concentration of H2B-GFP is approximately halved on division (Figure 1e Finally, to trace cell fate behaviour in human tissues, attention has focused on the ability of naturally occurring DNA mutations to serve as a hereditary label ( Figure 1i ).
In one approach, the accumulation of mitochondrial DNA mutation (mtDNA) [35, 36] has been used as a surrogate clonal marker [37, 38] . In a related approach, the acquisition of single nucleotide polymorphisms have been used as a hereditary mark allowing the allele frequency of clonally related cells to be recovered by exome deep sequencing [11, 22, 39] . Further, advances in single-cell DNA sequencing offer the potential to recover phylogenic information, with applications to both normal and diseased tissues [40] . However, although these approaches provide a valuable window on cell dynamics in human tissues, the neutrality of mtDNA and DNA mutations call into question their reliability.
Clonal distributions as a record of cell fate choice
Although the lineage potential and proliferative capacity of labelled cells is reflected in clone size and composition, for a given clone, such static measures can rarely select from among the multiplicity of potential fate histories the one was actually followed. However, if cell fate behaviour is conserved across a subpopulation, by recovering the distribution of clone size and cell composition from a statistical ensemble, analytical methods based on population dynamics and inference techniques can be used to select the model that best predicts the experimental outcome. By analogy, the balance of a weighted die cannot be discerned from a single throw; but it can be resolved from an analysis of a statistical ensemble of throws. Of course, with the innate complexity of a developing tissue, the challenge of deciphering pattern of cell fate choice from static clonal data may be better compared to recovering the rules of chess from the statistical ensemble of chessboard configurations! Fortunately, in many cases, the convergence of clone size distributions onto stereotypic behaviours allows rigorous aspects of cell dynamics to be inferred. For Outside homeostasis, the dynamics of clonal evolution is less restricted. As a result, the resolution of cell fate behaviour has proved more challenging. These difficulties are exacerbated by the escalation of clone merger and fragmentation events in growth. Nevertheless, when clonal data can be recovered, quantitative information on lineage potential can often be deciphered. In one example, by targeting radial glial-like (RGL) precursors using the MADM labelling system, quantitative analysis of sister clone size dependence has shown that mouse cortical neurogenesis relies on a remarkably deterministic cell-autonomous programme [48] . Through the correlation of sister clone sizes, these studies revealed that the entry of RGLs into their neurogenesis is not sporadic, but is tightly-regulated so that, in their proliferative phase, RGLs move sequentially through a defined cascade of symmetrical divisions.
Following entry into neurogenesis, RGLs then make a series of invariant asymmetric cell divisions, giving rise to a "quantal" neuronal output before finally entering into gliogenesis.
In a second case study, a multicolour 
